3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
11
Colorectal Neoplasms
10
Neoplasm Metastasis
6
Rhabdomyosarcoma
3
Neuroblastoma
3
Lung Neoplasms
3
Stomach Neoplasms
2
Small Cell Lung Carcinoma
2
Sarcoma, Ewing
2
Sarcoma
2
Rectal Neoplasms
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Esophageal Squamous Cell Carcinoma
2
Esophageal Neoplasms
2
Colonic Neoplasms
2
Cholangiocarcinoma
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Neuroendocrine
2
Biliary Tract Neoplasms
2
Uterine Cervical Neoplasms
1
Solid Tumors
1
Rhabdomyosarcoma, Embryonal
1
Rhabdomyosarcoma, Alveolar
1
Refractory Solid Tumors
1
Pancreatic Ductal Adenocarcinoma
1
Ovarian Neoplasms
1
Medulloblastoma
1
Malignant mesenchymal tumor
1
Intestinal Neoplasms
1
Gastrointestinal Neoplasms
1
Interventions
Cyclophosphamide
5
fludarabine phosphate
3
Vincristine
3
Methotrexate
3
Etoposide
3
pegaspargase
2
merphos
2
dexamethasone acetate
2
dexamethasone 21-phosphate
2
auricularum
2
Whole-Body Irradiation
2
Tacrolimus
2
Specimen Handling
2
Sirolimus
2
Peripheral Blood Stem Cell Transplantation
2
Leucovorin
2
Doxorubicin
2
Dexamethasone
2
Cytarabine
2
Calcium Dobesilate
2
venetoclax
1
prednylidene
1
hydrocortisone hemisuccinate
1
fludarabine
1
exifone
1
deltacortene
1
calaspargase pegol
1
azathiopurine
1
aldesleukin
1
Thioguanine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
×
Irinotecan
×
30 days
×
Clear all
No trials found.